GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons ...Middle East

NetworkNewsWire Editorial Coverage NEW YORK, Jan. 10, 2024 /PRNewswire/ -- On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 diabetes (T2D). However, it wasn't just a...

Hence then, the article about glp 1 beyond diabetes a blockbuster horizon beckons was published today ( Wednesday 10/01/2024 - 07:29 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons )

Also on site :

• Trump is desperate to sign this terrible $25bn deal – and it’s obvious why
• 13 US service members have died in the war with Iran. Here are their stories
• Is it illegal to park in a bike lane in Colorado?